| NCT04026984 | Evaluate Safety and Efficacy of Rifamycin SV MMX in the Treatment of Traveler's Diarrhea in Children Age 6 to 11 Years | NOT_YET_RECRUITING | PHASE2 | 2024-06 | 2025-12 | 2025-06 |
| NCT04027894 | Study to Evaluate Safety and Efficacy of Rifamycin SV MMX in Treating Traveler's Diarrhea in Children Age 12 to 17 Years | NOT_YET_RECRUITING | PHASE2 | 2024-01 | 2025-12 | 2025-01 |
| NCT04723537 | Upamostat, a Serine Protease Inhibitor, or Placebo for Treatment of COVID-19 Disease | TERMINATED | PHASE2, PHASE3 | 2021-02-16 | 2021-12-28 | 2021-12-28 |
| NCT04616924 | RHB-204 for the Treatment of Pulmonary Mycobacterium Avium Complex Disease | TERMINATED | PHASE3 | 2020-12-01 | 2023-08-28 | 2023-08-28 |
| NCT04467840 | Opaganib, a Sphingosine Kinase-2 (SK2) Inhibitor in COVID-19 Pneumonia | COMPLETED | PHASE2, PHASE3 | 2020-08-21 | 2021-07-18 | 2021-07-18 |
| NCT04502069 | Treatment of COVID-19 With Opaganib in Patients With Pneumonia Requiring Oxygen | WITHDRAWN | PHASE1, PHASE2 | 2020-08 | 2021-06 | 2021-02 |
| NCT04414618 | A Study of Opaganib in Coronavirus Disease 2019 Pneumonia | COMPLETED | PHASE2 | 2020-07-02 | 2020-12-23 | 2020-11-26 |
| NCT03377179 | A Study of ABC294640 Alone and in Combination With HCQ Sulfate in the Treatment of Advanced Cholangiocarcinoma | COMPLETED | PHASE2 | 2018-03-07 | 2022-06-21 | 2022-06-21 |
| NCT03198507 | ERADICATE Hp2 - Treating Helicobacter Pylori With RHB-105 Compared to Active Comparator | COMPLETED | PHASE3 | 2017-06-18 | 2018-12-13 | 2018-10-24 |
| NCT03009396 | Open Label Efficacy and Safety of Anti-MAP (Mycobacterium Avium Ssp. Paratuberculosis) Therapy in Adult Crohn's Disease | COMPLETED | PHASE3 | 2017-03-18 | 2019-08-19 | 2018-11-13 |
| NCT02757326 | ABC294640 (Opaganib) in Refractory / Relapsed Multiple Myeloma | TERMINATED | PHASE1, PHASE2 | 2016-12-13 | 2019-05 | 2019-05 |
| NCT02757105 | Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of BEKINDA (Ondansetron 12 mg Bimodal Release Tablets) for Diarrhea Predominant Irritable Bowel Syndrome (IBS-D) | COMPLETED | PHASE2 | 2016-05-19 | 2017-07-14 | 2017-06-16 |
| NCT02246439 | BEKINDA (Ondansetron 24 mg Bimodal Release Tablets) for Vomiting Due to Presumed Acute Gastroenteritis or Gastritis | COMPLETED | PHASE3 | 2014-12-08 | 2017-02-16 | 2017-02-13 |
| NCT02229981 | Early Phase Evaluation of ABC294640 in Patients With Refractory/Relapsed Diffuse Large B-cell Lymphoma or Kaposi Sarcoma | WITHDRAWN | PHASE1, PHASE2 | 2014-07 | 2019-12 | 2019-06 |
| NCT01980095 | ERADICATE Hp - Treating Helicobacter Pylori With RHB-105 | COMPLETED | PHASE3 | 2013-11 | 2015-08 | 2015-06 |
| NCT01951326 | Efficacy and Safety of Anti-MAP Therapy in Adult Crohn's Disease | COMPLETED | PHASE3 | 2013-09 | 2019-08 | 2018-05 |
| NCT01717664 | Proof of Concept Study of RHB-104 as Add-On Therapy to Interferon Beta-1a in Relapsing Remitting Multiple Sclerosis (RRMS) | COMPLETED | PHASE2 | 2013-06 | 2016-07 | 2015-12 |
| NCT01488513 | ABC294640 in Treating Patients With Advanced Solid Tumors | COMPLETED | PHASE1 | 2011-08 | 2015-07 | 2014-08 |